| Jun 21, 2012
| 4:03 PM
The stock purchases began in December 2008, less than two months after discussions kicked off about the corporate acquisition of a California medical products manufacturer.
By the time the deal was announced on Jan. 12, 2009, former Orioles third baseman...
| Aug 22, 2011
| 7:21 AM
As the Dow took another 400-point tumble Thursday, Baltimore money manager David Stepherson found himself talking one client out of selling everything.
"I advised him that it would not be a good idea because our view of things is that this is going to be...
| Aug 17, 2012
| 3:39 PM
Orioles Hall-of-Famer Eddie Murray has agreed to pay $358,151 to settle charges that he illegally profited from an insider trading scheme involving former teammate Doug DeCinces, the U.S. Securities and Exchange Commission announced Friday.
| Aug 20, 2014
| 5:20 AM
WASHINGTON Lawmakers are expected to return from their August recess with proposals to close a loophole that allows companies like Pennsylvania's Mylan Pharmaceuticals to avoid paying Uncle Sam by acquiring foreign competitors and reincorporating in...
| Aug 18, 2014
| 7:06 AM
NEW YORK (Reuters) - Procter & Gamble Co is working with advisors including Goldman Sachs Group as the world's largest household products maker reviews up to 100 underperforming brands for potential divestiture, people familiar with the matter said....
| Aug 18, 2014
| 7:28 AM
Abbott Laboratories and the Defense Department on Monday said they have agreed to a multiyear collaboration to develop portable blood tests to help evaluate concussions and other head injuries.
Lake County-based Abbott will receive $19.5 million over the...
| Aug 12, 2014
| 2:05 PM
Matter, a not-for-profit health tech hub in downtown Chicago slated to open in early 2015, on Tuesday named a chief executive and said it's taking applications for new tenants.
“What's been missing here in this (health technology) community is a...
| Aug 2, 2014
| 5:00 AM
It's both endearing and infuriating to watch American corporate executives wring their hands about how the injustices of the U.S. tax code are forcing them — forcing them! — to reincorporate overseas through the procedure known as inversion....
| Jul 18, 2014
While its peers in the northern suburbs and around the pharmaceutical industry have been lining up foreign mergers to help sidestep U.S. taxes, Baxter International said Thursday it has no plans to jump on the bandwagon.
The Deerfield-based health...
| Jul 18, 2014
| 8:43 AM
Illinois drug maker AbbVie Inc. said Friday it would buy European rival Shire for $55 billion and reincorporate in Britain, allowing the company to slash its tax rate in the latest move by an American firm to shelter its foreign earnings.
| Jul 17, 2014
| 6:55 AM
AbbVie Inc. is buying Shire for nearly $55 billion, the largest deal in a year filled with merger and acquisition activity, and the latest example of companies taking foreign addresses to cut taxes.
The deal will allow North Chicago-based pharmaceutical...
| Jul 19, 2014
AbbVie Inc. signed a nearly $55 billion deal to acquire drugmaker Shire PLC early Friday, a move that will allow it to substantially cut its corporate tax bill by moving its legal address to the United Kingdom.
The deal, announced by both companies in a...